Gadiano, Mary Grace P.
HRN: 23-46-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2023
CEFUROXIME 1.5GM (VIAL)
08/04/2023
08/10/2023
IV
1g
Q8hours
T/c UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes